Comera Life Sciences Holdings, Inc. (CMRA)

NASDAQ: CMRA · Delayed Price · USD
2.50
-0.89 (-26.25%)
At close: May 27, 2022 4:00 PM
2.48
-0.02 (-0.80%)
After-hours:May 27, 2022 6:08 PM EDT
Market Cap9.77M
Revenue (ttm)319,832
Net Income (ttm)-5.45M
Shares Out3.91M
EPS (ttm)0.17
PE Ratio14.53
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume828,908
Open2.50
Previous Close3.39
Day's Range2.50 - 3.08
52-Week Range2.50 - 11.44
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About CMRA

As of May 19, 2022, OTR Acquisition Corp. was acquired by Comera Life Sciences Holdings, Inc., in a reverse merger transaction. OTR Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Miami, Florida.

IndustryShell Companies
Founded2014
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolCMRA
Full Company Profile

Financial Performance

In 2021, CMRA's revenue was $319,832, a decrease of -27.79% compared to the previous year's $442,919. Losses were -$5.45 million, 156.5% more than in 2020.

Financial Statements

News

What's Going On With OTR Acquisition Stock Today?

OTR Acquisition Corp (NASDAQ: OTRA) shares are trading higher Wednesday after the company filed a Form 8-K with the U.S. Securities and Exchange Commision. The move appears to be related to the high num...

1 week ago - Benzinga

Why Is OTR Acquisition (OTRA) Stock Up Today?

The shares of OTR Acquisition are climbing after the SPAC's shareholders overwhelmingly approved a merger with Comera. The post Why Is OTR Acquisition (OTRA) Stock Up Today?

2 weeks ago - InvestorPlace

Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Form...

WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera” or the “Company”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and c...

2 weeks ago - Business Wire

Comera Life Sciences to Present at 18th Annual PEGS Boston Conference & Expo

WOBURN, Mass.--(BUSINESS WIRE)--Comera Life Sciences, Inc., which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, today announced ...

1 month ago - Business Wire

Comera Life Sciences and Intas Pharmaceuticals Announce Research Collaboration

WOBURN, Mass. & AHMEDABAD, India--(BUSINESS WIRE)--Today, Comera Life Sciences, Inc. (“Comera” or the “Company”) and Intas Pharmaceuticals Ltd. (“Intas”) announced a research collaboration to develop a ...

1 month ago - Business Wire

Comera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business...

WOBURN, Mass. & MIAMI--(BUSINESS WIRE)--Comera Life Sciences, Inc. (“Comera”), which is developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenienc...

1 month ago - Business Wire